Scotiabank Initiates Broad Pharma Coverage; Global Markets See Mixed Performance

Key TakeawaysScotiabank initiated "sector outperform" ratings on five major pharmaceutical and biotech firms—Gilead, Eli Lilly, Merck, Amgen, and Johnson & Johnson—setting ambitious price targets ranging from $105 to $1165.Global markets exhibited varied performance, with Australia's ASX 200 Index dropping 0.52% to 8753.40 points, while Japan's super long bond yields eased following a firm auction outcome.In the energy sector, Gerdes Energy Research raised its price target for Chevron Corp to $171, reflecti ...